Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001140361-25-005540 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-21 | 2025-02-19 | ADMA | KWON YOUNG | Dir | A - Grant | $0.00 | -10.9K | 252.3K | -4% | $0 |
| D | 2025-02-21 | 2025-02-19 | ADMA | KWON YOUNG | Dir | A - Grant | $0.00 | +16.3K | 16.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | A | D | 10,889 | $0.00 | 252,330 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date. (F2) Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 RSUs granted on February 26, 2024, which will vest in full on February 26, 2024, subject to the Reporting Person's continued service as of such vesting date; and (iii) 229,421 shares of common stock owned by the reporting person. |
| 2 | Derivative | Stock Option (right to buy) | 2025-02-19 | A | A | 16,279 | $0.00 | 16,279 | D | $16.07 · — to 2035-02-19 | 16,279 Common Stock | (F3) The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant. |